Judith A. Fox, Ph.D.
Chief Scientific Officer and Executive Vice President, Research & Development
Judy Fox, Ph.D. rejoined Sunesis in 2017 as Chief Scientific Officer where she previously served as Vice President, Product & Preclinical Development. She has over 25 years of experience both as a scientist and program leader from companies including Genentech, Chiron and emerging immuno-oncology companies. Her career has focused on the translation of basic mechanistic understanding of promising drugs into coherent, evidence-based clinical development. Previously, she was Senior Director in Translational Sciences at Chiron Corporation and she established the Pharmacological Sciences Department at Genencor International. Dr. Fox’s industry career began at Genentech, Inc. where she contributed to the development of products such as Herceptin®, Xolair®, Raptiva® and Avastin®. Dr. Fox received her Ph.D. in Biological Chemistry from the Massachusetts Institute of Technology, where she serves on the Chemistry Visiting Committee, and an A.B. in Chemistry from Bryn Mawr College. She conducted postdoctoral research at The Rockefeller University.